135 related articles for article (PubMed ID: 24977160)
1. Synthesis and anticancer activity of N-aryl-5-substituted-1,3,4-oxadiazol-2-amine analogues.
Ahsan MJ; Sharma J; Singh M; Jadav SS; Yasmin S
Biomed Res Int; 2014; 2014():814984. PubMed ID: 24977160
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and in vitro anticancer evaluation of novel 2,5-disubstituted 1,3,4-oxadiazole analogue.
Salahuddin ; Mazumder A; Shaharyar M
Biomed Res Int; 2014; 2014():491492. PubMed ID: 25177693
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, ADME, and Anticancer Studies of Newer
Agarwal M; Afzal O; Salahuddin ; Altamimi ASA; Alamri MA; Alossaimi MA; Sharma V; Ahsan MJ
ACS Omega; 2023 Aug; 8(30):26837-26849. PubMed ID: 37593245
[TBL] [Abstract][Full Text] [Related]
4. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents.
Kumar D; Patel G; Chavers AK; Chang KH; Shah K
Eur J Med Chem; 2011 Jul; 46(7):3085-92. PubMed ID: 21481985
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
Rashid M; Husain A; Mishra R
Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
[TBL] [Abstract][Full Text] [Related]
12. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
13. 3-(4-chlorophenyl)-[1, 2, 3] oxadiazol-3-ium-5-olate and its 4-formyl analog-Ultrasound assisted synthesis and in-vitro anticancer evaluation against human tumor cell lines.
Bhosale SK; Deshpande SR; Wagh RD
Pak J Pharm Sci; 2017 Mar; 30(2):513-520. PubMed ID: 28649078
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.
Hamdy R; Ziedan NI; Ali S; Bordoni C; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2017 Feb; 27(4):1037-1040. PubMed ID: 28087272
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
Du K; Cao X; Zhang P; Zheng H
Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies.
Purohit M; Prasad VV; Mayur CY
Arch Pharm (Weinheim); 2011 Apr; 344(4):248-54. PubMed ID: 21469174
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Anticancer Activity of Curcumin Analogues Bearing a Heterocyclic Nucleus.
Ahsan MJ; Ahsan MJ
Asian Pac J Cancer Prev; 2016; 17(4):1739-44. PubMed ID: 27221847
[TBL] [Abstract][Full Text] [Related]
20. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T
Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
